Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients

NCT05754047 · clinicaltrials.gov ↗

COMPLETED

Status

3582

Enrollment

OTHER

Sponsor class

Conditions

HER2 Low Breast Carcinoma

Interventions

DIAGNOSTIC_TEST: immunohistochemistry (IHC) and in situ hybridization (ISH) Test

Sponsor

Mahdis Bayat